UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Recognizing when to seek financial planning help can significantly impact your financial health. Discover the key signs that indicate it's time to reach out.
22,901 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
NVIDIA faces a supply bottleneck at its chipmaker that could cap near-term revenue even as AI demand remains strong. ...
As Berkshire Hathaway prepares for a new era, Warren Buffett successor Greg Abel may be quietly orchestrating a bold,...
Developers race to add native privacy to Ethereum as investors rotate into privacy-first assets. A 12-month deadline ...
Costco faces a pivotal question for 2029: can it sustain double-digit earnings growth and margin resilience to lift C...
Vistra's Q1 2026 results shed light on margin dynamics across generation, retail, and renewables. This guide breaks d...
Lululemon posted a mixed quarter: international sales led growth while the core US market softened. This analysis dig...
Solana outpaced peers as the sol/btc ratio hits monthly high, sparking bets that SOL could test $100 even as Bitcoin ...
Crypto traders wager on SpaceX ahead of its Nasdaq debut, driving more than $1 billion in SPCX perpetual futures over...
The U.S. government imposed new restrictions on releasing a major AI model, triggering immediate market moves. Analys...
Shiba Inu’s key on-chain metric has dropped to a five-year low, signaling caution but also a possible setup for a fut...
Iran asserts a new permission and insurance framework for crossing the Strait of Hormuz, while ships continue to move...